Pharma Tips

NPPA cuts prices of malaria, HIV, cancer drugs by up to 45%

By: Pharma Tips | Views: 665 | Date: 18-Nov-2016

Prices of 22 essential drugs used for treatment of cancer, HIV, bacterial infections and malaria among others, have been capped by the government, reducing the cost in the range of 10-45 per cent.

NPPA cuts prices of malaria, HIV, cancer drugs by up to 45%

Prices of 22 essential drugs used for treatment of cancer, HIV, bacterial infections and malaria among others, have been capped by the government, reducing the cost in the range of 10-45 per cent.

Drug price regulator NPPA has also fixed the retail price of 13 formulations.

"NPPA has fixed/revised ceiling prices of 22 scheduled formulations of Schedule-I under Drugs (Price Control) Amendment Order, 2016 and retail price of 13 formulations under DPCO, 2013," the National Pharmaceutical Pricing Authority (NPPA) said in a statement.

When contacted, NPPA Chairman Bhupendra Singh said, "The prices have been reduced in the range of 10 to 45 per cent. While the prices of some drugs have been reduced by 10 per cent, prices of others have been cut by up to 45 per cent."

As stipulated under the Drugs (Prices Control) Order (DPCO) 2013, NPPA fixes ceiling price of essential medicines of Schedule I.

In respect of medicines not under price control, manufacturers are allowed to increase the maximum retail price by 10 per cent annually.

The calculation for essential drugs is based on the simple average of all medicines in a particular therapeutic segment with sales of more than 1 per cent.

The government had notified the DPCO 2013, which covers 680 formulations, with effect from May 15, 2014, replacing the 1995 order that regulated prices of only 74 bulk drugs.

Set up in 1997, NPPA has been entrusted with the task of fixation/revision of prices of pharma products, enforcement of provisions of DPCO and monitoring of prices of controlled and decontrolled drugs.

Previous Page Next Page

People Searching On This Page:

Related Pages


Govt cuts coronary stent prices by 85 percent in major relief to cardiac patients

Govt cuts coronary stent prices by 85 percent in major relief to cardiac patients

News
Date:
15-Feb-2017  Views: 914

New Delhi: In a major relief to lakhs of cardiac patients, the government on Tuesday cut prices of life-saving coronary stents by up to 85 percent by ...
B.Pharm/M.Pharm for Drugs Inspector under Directorate of Drugs control

B.Pharm/M.Pharm for Drugs Inspector under Directorate of Drugs control

Jobs | Drug Inspector
Date:
02-Mar-2016  Views: 22053

Online applications are invited from Indian Citizen and such other national as declared eligible by Government of India for recruitment to the 88 post ...
Cipla, Pfizer, Sanofi cut prices of diabetic, cardiac drugs

Cipla, Pfizer, Sanofi cut prices of diabetic, cardiac drugs

News | Pharmaceutical Drugs
Date:
12-Sep-2014  Views: 892

Cipla, Pfizer and Sanofi have started supplying drugs capped in the anti-diabetic and cardio-vascular segments as per the July 10 NPPA notification wh ...
National Cancer Research Institute (NCRI) Cancer Conference 2013

National Cancer Research Institute (NCRI) Cancer Conference 2013

News | Exhibitions & Conferences
Date:
02-Sep-2013  Views: 1468

About NCRIThe NCRI is a UK-wide partnership between government, charity and industry, which promotes co-operation in cancer research. Our 22 member or ...
Classification of AntiCancer Drugs

Classification of AntiCancer Drugs

Articles | Pharmacology
Date:
28-Sep-2011  Views: 45526

1.Polyfunctional alkylating agents 2.Other Alkylating Drugs 3.Antimetabolites 4.Purine antagonists 5.Pyrimidine antagonists 6.Plant alkaloids 7.Antib ...
Post Your Comments (No Login Require)
Name : (required)
Email : (required)
Website :

Comment : (required)

33  + 1 =     
Comments

Google : 20 times | Yahoo : 5 times |